Skip to content

Intraoperative nausea and vomiting effect compared in different group of drugs among the elective cesarean section cases.

"COMPARISON OF THE EFFECT OF PROPOFOL AND METOCLOPRAMIDE ON INTRAOPERATIVE NAUSEA, VOMITING AND RETCHING IN PARTURIENT UNDERGOING ELECTIVE CESAREAN SECTION- A RANDOMIZED CLINICAL TRIAL." - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/09/074313
Enrollment
116
Registered
2024-09-25
Start date
Unknown
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O754- Other complications of obstetric surgery and procedures

Interventions

Intervention1: metoclopramide, propofol, metoclopramide plus propofol, normal saline. : Administration of metoclopramide and propofol in elective cesarean sections to prevent intraoperative nausea and

Sponsors

SHRI B M Patil Medical College Hospital Research Centre BLDEDU
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Pregnant female of age 20 - 35 years Gestational age more than 36 weeks and less than 41 weeks undergoing elective cesarean sections.

Exclusion criteria

Exclusion criteria: Patients with BMI more than 35kg/m.sq. Patient with emergency cesarean section with fetal and maternal distress. Hemoglobin less than 10mg/dl Patient with known allergy to study medications. Patients having significant cardiopulmonary, hepatic or renal insufficiency. Predicted fetal weight less than 2.5kg. Patients with any major abdominal surgeries.

Design outcomes

Primary

MeasureTime frame
To compare the intraoperative nausea, vomiting and retching between different groups using the NRS scale. Timepoint: Every 5mins for first 30mins, followed by every 15mins till clamping of cords.

Secondary

MeasureTime frame
To compare the maternal sedation score after surgery in study groups. To compare the APGAR score for neonates in all the study groups. To compare any associated adverse effects in all the study groups.Timepoint: 1.5- 2 hours.

Countries

India

Contacts

Public ContactDr. Basavaraj Patil

BLDE (DEEMED TO BE UNIVERSITY).

drbnp2000@gmail.com7829655342

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026